Adipocyte-specific pathways regulating PLIN1 and GLUT4 gene expression

Adipocyte-specific pathways regulating PLIN1 and GLUT4 gene expression represent a coordinated regulatory network essential for maintaining systemic metabolic health. Perilipin-1 (PLIN1) is a protein that coats lipid droplets in adipocytes, playing a dual role in protecting stored lipids from basal lipolysis and facilitating stimulated lipolysis when energy is needed (Source: UniProt P43354). GLUT4 is the primary insulin-responsive glucose transporter responsible for clearing glucose from the blood into adipose and muscle tissues (Source: UniProt P14672). These pathways are centrally regulated by the transcription factor Peroxisome Proliferator-Activated Receptor gamma (PPARG), which ensures the proper expression of these genes to support adipocyte function and insulin sensitivity (Source: PubMed ID 17006483). In conditions such as obesity and type 2 diabetes, these pathways are often impaired, leading to reduced glucose uptake and dysregulated lipid storage. Pharmacological agents like thiazolidinediones (TZDs) target this network by activating PPARG, thereby restoring the expression of PLIN1 and GLUT4 to improve glycemic control and lipid metabolism (Source: StatPearls, Thiazolidinediones). However, the systemic activation of these pathways can lead to side effects such as weight gain and fluid retention, necessitating careful clinical management.

Other names

Adipocyte gene regulatory networkPPARG-mediated regulation of PLIN1 and GLUT4Adipocyte metabolic pathways

The primary mechanism involves the activation of the nuclear receptor PPAR-gamma, which acts as a transcription factor to upregulate the expression of PLIN1 and GLUT4. PPAR-gamma binds to Peroxisome Proliferator Response Elements (PPREs) in the promoter regions of these genes, facilitating the recruitment of transcriptional co-activators and increasing mRNA synthesis (Source: PubMed ID 10339487, 17006483).